Evidence map›Paper›PMID 33408345›Full record

ArticleCellular & molecular immunology2021

Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.

Marc Permanyer, Berislav Bošnjak, Silke Glage, Michaela Friedrichsen, Stefan Floess, Jochen Huehn, Gwendolyn E Patzer, Ivan Odak, Nadine Eckert, Razieh Zargari and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 41 citations in OpenAlex.

  1. Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Notch2-expressing CD4Cellular & molecular immunology · 2025
    Article
  11. Reprogramming intratumoral TScience immunology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Marc PermanyerInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Berislav BošnjakInstitute of Immunology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-3374-7488
Silke GlageInstitute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany.
Michaela FriedrichsenInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Stefan FloessDepartment Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Jochen HuehnDepartment Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID http://orcid.org/0000-0001-8071-1379
Gwendolyn E PatzerInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Ivan OdakInstitute of Immunology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-0408-5091
Nadine EckertInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Razieh ZargariInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Laura Ospina-QuinteroInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Hristo GeorgievInstitute of Immunology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-1369-960X
Reinhold FörsterInstitute of Immunology, Hannover Medical School, Hannover, Germany. foerster.reinhold@mh-hannover.de.
Medizinische Hochschule Hannover · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signaling via interleukin-2 receptor (IL-2R) is a requisite for regulatory T (Treg) cell identity and function. However, it is not completely understood to what degree IL-2R signaling is required for Treg cell homeostasis, lineage stability and function in both resting and inflammatory conditions. Here, we characterized a spontaneous mutant mouse strain endowed with a hypomorphic Tyr129His variant of CD25, the α-chain of IL-2R, which resulted in diminished receptor expression and reduced IL-2R signaling. Under noninflammatory conditions, Cd25

Indexed as

MutationAnimalsColitisFemaleForkhead Transcription FactorsHomeostasisImmunosuppression TherapyInterleukin-2Interleukin-2 Receptor alpha SubunitMaleMiceMice, Inbred C57BLSignal TransductionT-Lymphocytes, RegulatoryForkhead Transcription FactorsIl2ra protein, mouseInterleukin-2Interleukin-2 Receptor alpha SubunitIL-2R signalingRegulatory T cellsscRNA sequencingTreg heterogeneity

Identifiers

PMID33408345
PMCPMC8027001
OpenAlexW3120208600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.